The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Young David since 2010.
This trader's CIK number is 1378166.
At the time of last reporting, Young David was the Pres. Research & Development of Processa Pharmaceuticals, Inc.. (stock ticker symbol PCSA).
Also see all insider trading activities at Processa Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | QCOR | 0 | $0 | 24,000 | $1,784,658 | 50,000 | $294,380 |
| 2013 | QCOR | 0 | $0 | 100,000 | $6,240,000 | 115,000 | $540,550 |
| 2012 | QCOR | 0 | $0 | 70,000 | $2,996,700 | 80,625 | $349,728 |
| 2011 | QCOR | 0 | $0 | 105,124 | $4,063,624 | 100,000 | $381,499 |
| 2010 | QCOR | 0 | $0 | 28,125 | $346,893 | 28,125 | $25,959 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | PCSA | 124,500 | $99,351 | 0 | $0 | 17,272 | $0 |
| 2024 | PCSA | 20,000 | $50,500 | 0 | $0 | 3,994 | $0 |
| 2023 | PCSA | 80,000 | $40,000 | 0 | $0 | 0 | $0 |
1. Questcor Pharmaceuticals Inc (QCOR)
2. Processa Pharmaceuticals, Inc. (PCSA)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-06-24 | QCOR | Sale | 6,000 | 91.96 | 551,766 |
| 2014-06-24 | QCOR | Option Ex | 6,000 | 4.54 | 27,240 |
| 2014-03-14 | QCOR | Option Ex | 6,000 | 4.54 | 27,240 |
| 2014-03-14 | QCOR | Sale | 6,000 | 62.22 | 373,308 |
| 2014-03-03 | QCOR | Option Ex | 6,000 | 5.77 | 34,620 |
| 2014-02-24 | QCOR | Sale | 6,000 | 78.88 | 473,292 |
| 2014-02-24 | QCOR | Option Ex | 6,000 | 4.54 | 27,240 |
| 2014-01-29 | QCOR | Option Ex | 20,000 | 7.54 | 150,800 |
| 2014-01-24 | QCOR | Option Ex | 6,000 | 4.54 | 27,240 |
| 2014-01-24 | QCOR | Sale | 6,000 | 64.38 | 386,292 |
| 2013-11-19 | QCOR | Option Ex | 15,000 | 5.77 | 86,550 |
| 2013-11-13 | QCOR | Option Ex | 100,000 | 4.54 | 454,000 |
| 2013-11-13 | QCOR | Sale | 100,000 | 62.40 | 6,240,000 |
| 2012-08-10 | QCOR | Option Ex | 10,625 | 3.00 | 31,928 |
| 2012-04-27 | QCOR | Option Ex | 70,000 | 4.54 | 317,800 |
| 2012-04-27 | QCOR | Sale | 70,000 | 42.81 | 2,996,700 |
| 2011-10-31 | QCOR | Sale | 79,724 | 41.22 | 3,285,824 |
| 2011-10-31 | QCOR | Option Ex | 75,000 | 4.54 | 340,500 |
| 2011-08-12 | QCOR | Option Ex | 9,208 | 1.64 | 15,101 |
| 2011-08-12 | QCOR | Sale | 9,308 | 32.00 | 297,856 |
| 2011-08-15 | QCOR | Option Ex | 5,792 | 1.64 | 9,498 |
| 2011-08-15 | QCOR | Sale | 6,092 | 32.00 | 194,944 |
| 2011-08-05 | QCOR | Option Ex | 10,000 | 1.64 | 16,400 |
| 2011-08-05 | QCOR | Sale | 10,000 | 28.50 | 285,000 |
| 2010-11-02 | QCOR | Option Ex | 28,125 | .92 | 25,959 |
| 2010-11-02 | QCOR | Sale | 28,125 | 12.33 | 346,893 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-04-01 | PCSA | Option Ex | 17,272 | .00 | 0 |
| 2025-01-27 | PCSA | Buy | 124,500 | .80 | 99,351 |
| 2024-07-10 | PCSA | Option Ex | 644 | .00 | 0 |
| 2024-04-05 | PCSA | Option Ex | 1,675 | .00 | 0 |
| 2024-01-01 | PCSA | Option Ex | 1,675 | .00 | 0 |
| 2024-02-06 | PCSA | Buy | 20,000 | 2.52 | 50,500 |
| 2023-04-14 | PCSA | Buy | 20,000 | .55 | 11,000 |
| 2023-04-13 | PCSA | Buy | 20,000 | .48 | 9,600 |
| 2023-04-12 | PCSA | Buy | 20,000 | .45 | 9,000 |
| 2023-04-11 | PCSA | Buy | 20,000 | .52 | 10,400 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Young David (Pres. Research & Development of Processa Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.